WiCON | Pharma China (Web Edition)

WiCON International Group
21 Bridge Street
Metuchen, NJ 08840, USA
Tel/Fax: +1 801-751-5728
info@pharmachinaonline.com

Affiliated Companies
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

BJ Jicai PharmTech
Oriental Kenzo Plaza
Beijing, China
Tel: +86 10 84476010
info@pharmachinaonline.com

China Sharpens Focus on Healthcare Cost Containment amid a Basket of Mixed Sig... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with emphasis on latest market data, intensifying healthcare cost containment, as well ...
(10/12/2020)

China Signs Off on PRC Biosecurity Law: What T... (10/23/2020)

Amgen's China Strategy Forward: Collaborating ... (10/23/2020)

Gowling WLG: Ten Highlights of China's New Pat... (10/22/2020)

Nation's Healthcare Expands to Cover All Urban... (10/22/2020)

China's Newly Approved Amendment to Patent Law... (10/22/2020)

China's Draft Measures on Patent Linkage: Impl... (10/21/2020)

China Forges Ahead with Draft Measures for New... (10/21/2020)

SCMP: IP Theft? China's Tougher Patent Law Bri... (10/20/2020)

NLR: Five Changes in China's Newly Amended Pat... (10/19/2020)

First Pre-trial Injunction Granted for A Drug ... (10/19/2020)

Recent Executive Moves (10/23/2020) CDE Issues the General Requirements for ... (10/23/2020) Follow WiCON|Pharma China on Twitter and... (10/23/2020) (Free) COHGRM Issues Notice on Further Optimizi... (10/22/2020) CDE Issues the Two Generic Drug Research... (10/22/2020) CDE Issues the Guidance for Acceptance a... (10/22/2020) Priority Review Granted to Ascentage Pha... (10/22/2020) (Free) Fosun-owned Gland Pharma Granted Approva... (10/22/2020) AstraZeneca and Realcan Pharma Enter Dis... (10/22/2020) BioNTech to Make in Germany the Covid-19... (10/22/2020) Fujifilm and Carelink Form Partnership S... (10/21/2020) CDE Issues the Two Guidelines on Package... (10/21/2020) CDE Issues Notice on Supplemental Inform... (10/21/2020) CDE Seeks Comments on Draft ICH Guidelin... (10/21/2020) China Pharmaceutical Guide 2020 (15th Ed... (10/21/2020) (Free) Hogan Lovells: China Adopts Revised Pate... (10/21/2020)

China Pharmaceutical Guide 2020 (15th Ed) Now Available WiCON Publishes the China Pharmaceutical Guide 2020 (15... IQVIA: Chinese Hospital Drug Market Down 15.3% in Q2/20... NH Reports MAT Q1/2020 Data on the Chinese Cough, Cold ... IQVIA: China Represents 11% of Global Vaccine Market

Follow WiCON|Pharma China on Twitter and Facebook for L... BioNTech to Make in Germany the Covid-19 Vaccine for Ch... AstraZeneca and Realcan Pharma Enter Distribution Deal ... Fosun-owned Gland Pharma Granted Approval for Indian IP... Chinese Online Pharmacy Dingdang Kuaiyao Raises CNY 1B

CDE Issues the General Requirements for Oral Tablet Sco... CDE Issues the Guidance for Acceptance and Evaluation o... CDE Issues the Two Generic Drug Research Guidelines for... COHGRM Issues Notice on Further Optimizing the Administ... CDE Seeks Comments on Draft ICH Guideline Q2D(R2)

NHSA Announces the Final List of Drugs Passing Form Eva... NHSA Launches Trial for Regional Point Method-based Glo... The Average Chinese Life Expectancy Surges to 77.3 Year... China: BMI Fund Cannot Afford to Cover Vaccinations NHSA and MOF Issues Joint Notice to Advance the Trial f...

Hogan Lovells: China Adopts Revised Patent Law with Hat... NPC Approves Amended Patent Law of PRC, Benefiting Drug... SAMR Solicits Comments on the Draft Guide to Antimonopo... China Reviews Proposed Drug Patent Link Related Amendme... NHC Solicits Public Comments on PRC Law on Prevention a...

India Probes Alleged API Dumping by Chinese Companies China Increases Prices of Key Drug Ingredients by Up To... U.S. Introduces A 'Buy American First' Pharma Executive... Fitch: No Near-Term Impact on Chinese API Makers as Pha... Indian Firms Challenged by API Price Hikes by Chinese S...

Priority Review Granted to Ascentage Pharma's NDA for O... Daiichi Sankyo Submits IND Application for ADC Medicine... Eisai's sNDAs for Anti-Epileptic Drug Fycompa Accepted ... Antengene Establishes New Drug Discovery Center in Shan... Fosun's Hengenix to Initiate Trial of COVID-19 Antibody...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

2020 Fall/Winter Promotion - Pharma China publications USTR Satisfied with China's Implementatin of Phase 1 US... U.S.-China ESRC Hearing: China's Evolving Healthcare Sy... AmCham Survey: Supply Chain Challenges for US Companies... Upcoming Event: 2nd World Congress on Dermatology and A...

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

Pharma China on Twitter and Faceboo... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON to Hold Pharma China Annual F... WiCON Publishes the China Pharmaceu...